July 18: Courts and Researchers are Increasingly Focused on Genomics in Mass Tort Cancer Cases

Topics for discussion include:

• Flexible reporting of sequencing results
• Recent genomics rulings and motions
• Examples of genetic data missing from medical records
• Litigating the consequences of missing genetic data
• Prevalence of genomic mesotheliomas estimated at 20%
• Leveraging the value of tumor sequencing data
• CADD scores and VAF percentages
• Key recent papers on genomics and asbestos cancers
• Obtaining genetic data from commercial sequencing businesses
• Flexible reporting of sequencing results
• Trio sequencing for birth defects and parental exposure.cases.

Title:

Courts and Researchers are Increasingly Focused on Genomics in Mass Tort Cancer Cases

Date+Time:
July 18, 2024
2:00-3:30 p.m. ET

Register Now for this free Continuing Legal Education Webinar!
Speakers:
Kirk T. Hartley, Principal at LSP Group and ToxicoGenomica
Leonel van Zyl, PhD., ToxicoGenomica, CEO, ArrayXpress Inc.
Michael Zapata III, Executive Chairman, ArrayXpress, Inc. and Protochips Inc.
CLE Credit:

Complimentary registration comes with CLE credit in one state and will be available in California, Illinois, New Jersey, New York, Ohio, Pennsylvania, and Texas.

By:

Perrin Conferences. Sponsored by ToxicoGenomica.

More Information And Registration